Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact

Anonymous sources


Pancreatic beta cells produce insulin and play a critical role in maintaining blood glucose levels; loss of these cells results in the development of diabetes. A primary goal in diabetes therapy is beta cell replacement; however, there is a short supply of donor pancreases and a need for alternative sources of beta cells. Xiangwei Xiao and colleagues examined adult mouse pancreases to determine if they are capable of making new beta cells (beta cell neogenesis). They generated mice that express different fluorescent reporters in a time sensitive manner, so that insulin producing cells produce GFP (green) while all other cells produce mTomato (red). Cells that develop into beta cells should transiently co-express both GFP and mTomato, appearing yellow. By tracking the mice throughout their development, Xiao and colleagues found that beta cell neogenesis primarily takes place during embryogenesis, decreases dramatically after birth, and is completely absent in adult mice. The accompanying confocal microscopy image shows the developing embryonic mouse pancreas. Developing beta islets (yellow) are visible in the left and middle panels (Embryonic day 13.5 and 14.5, respectively), but have completely disappeared by embryonic day 15.5 (right panel), leaving only fully-developed beta islets (green). These results demonstrate that beta cell neogenesis only occurs for a short period of time during development, but not in adult mice.

Published April 24, 2013, by Jillian Hurst

Scientific Show Stopper

Related articles

No evidence for β cell neogenesis in murine adult pancreas
Xiangwei Xiao, … , John Wiersch, George K. Gittes
Xiangwei Xiao, … , John Wiersch, George K. Gittes
Published April 24, 2013
Citation Information: J Clin Invest. 2013;123(5):2207-2217. https://doi.org/10.1172/JCI66323.
View: Text | PDF
Research Article

No evidence for β cell neogenesis in murine adult pancreas

  • Text
  • PDF
Abstract

Whether facultative β cell progenitors exist in the adult pancreas is a major unsolved question. To date, lineage-tracing studies have provided conflicting results. To track β cell neogenesis in vivo, we generated transgenic mice that transiently coexpress mTomato and GFP in a time-sensitive, nonconditional Cre-mediated manner, so that insulin-producing cells express GFP under control of the insulin promoter, while all other cells express mTomato (INSCremTmG mice). Newly differentiated β cells were detected by flow cytometry and fluorescence microscopy, taking advantage of their transient coexpression of GFP and mTomato fluorescent proteins. We found that β cell neogenesis predominantly occurs during embryogenesis, decreases dramatically shortly after birth, and is completely absent in adults across various models of β cell loss, β cell growth and regeneration, and inflammation. Moreover, we demonstrated upregulation of neurogenin 3 (NGN3) in both proliferating ducts and preexisting β cells in the ligated pancreatic tail after pancreatic ductal ligation. These results are consistent with some recent reports, but argue against the widely held belief that NGN3 marks cells undergoing endocrine neogenesis in the pancreas. Our data suggest that β cell neogenesis in the adult pancreas occurs rarely, if ever, under either normal or pathological conditions.

Authors

Xiangwei Xiao, Zean Chen, Chiyo Shiota, Krishna Prasadan, Ping Guo, Yousef El-Gohary, Jose Paredes, Carey Welsh, John Wiersch, George K. Gittes

×
Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts